UK Protection Insurance 2017: Critical Illness & Income Protection

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

"UK Protection Insurance 2017: Critical Illness & Income Protection", discusses income protection and critical illness insurance, looking at market size with regards to changes in contracts and premiums, in addition to claims. It highlights the barriers to consumer engagement, how products are distributed, and the main market players and their propositions. It provides five-year forecasts of market size in premiums to 2021, and discusses how the market is likely to change as healthcare technology is developed.

The income protection and critical illness insurance markets continued to grow in 2016. Their year-on-year percentage growth outstripped the total protection market, highlighting a growing market for illness- and injury-oriented products. However, together they still only account for less than 10% of the total protection market in terms of contracts and premiums. Protection products remain complex, and are still sold and not bought, making advisors key to distribution. Income protection in particular is highly reliant on advisors, and this is not likely to change soon. Meanwhile, individuals are beginning to purchase critical illness insurance independently online without advice, although advisors will remain key. To maintain market growth, providers and advisors must continue to build consumer engagement with these products.

Scope

– Income protection grew by 7.4% to 119,459 in contracts and 10.8% to £48.3m in premiums from 2015 to 2016.

– Standalone critical illness insurance grew by 50.5% to 28,751 in contracts and 47.3% to £14.1m in premiums from 2015 to 2016.

– Legal & General dominates the critical illness insurance market, holding a 25.4% market share in 2016. LV= and Friends Life dominate the income protection market, with 27.3% and 23.1% shares respectively in 2016.

Reasons to Buy

– Understand the barriers of uptake for critical illness and income protection, and learn how to increase consumer engagement.

– Explore how the distribution landscape is changing for these products.

– Discover which providers lead the critical illness and income protection markets.

– See how critical illness and income protection are forecast to grow over the next five years.

Legal & General
Aviva
Vitality
Friends Life
Royal London
LV=
AIG

Table of Contents

Table of Contents

1. EXECUTIVE SUMMARY 3

1.1. Growing consumer engagement with IP and CII is vital 3

1.2. Key findings 3

1.3. Critical success factors 3

2. MARKET DYNAMICS 10

2.1. Introduction 10

2.2. The protection market has reached a new normal following the RDR 10

2.2.1. Contract levels for protection products reduced in the wake of the RDR 10

2.2.2. Protection is sold and not bought, making advisors key to the market 11

2.3. Contracts and premiums for IP and CII grew in 2016 12

2.3.1. IP and CII increased their share of the total protection market 12

2.3.2. The IP market continued to grow in 2016 15

2.3.3. The success of IP policies is due to products that cap payout duration at two years 16

2.3.4. Standalone CII has grown, but remains small compared to the total protection market 17

2.3.5. There are 16 times as many CII contracts sold as a with-rider product than standalone 18

2.3.6. Mortgage-related term customers are most likely to choose CII as a rider 19

2.3.7. Cross-selling CII as a rider product will be the easiest way to grow the CII market 19

2.3.8. The group protection market is shrinking 20

2.4. Consumer engagement with CII and IP is still relatively low 22

2.4.1. The 7 Families campaign helped raise awareness of protection products 22

2.4.2. The Building Resilient Households project looks to promote IP 23

2.4.3. There is confusion around the different types of protection products available 23

2.4.4. Only one in 10 people have IP in place 23

2.4.5. There is confusion around what employers and the government will provide 23

2.4.6. Individuals do not believe they will need protection products 24

2.4.7. Protection products are seen as a luxury purchase, and the application process is long 24

2.5. Over 90% of CII and IP claims received are paid 24

2.5.1. Cancer is the largest cost for critical illness insurers due to the high number of claims 24

2.5.2. The ABI is consulting whether stage one cancers should be excluded from full payment 25

2.5.3. 93.1% of CII claims submitted were paid in 2016 25

2.5.4. Mental illness is the highest claims cost for IP insurers 26

3. DISTRIBUTION DYNAMICS 28

3.1. RDR has changed the distribution landscape 28

3.1.1. The total protection market shows a decline in the restricted advice channel 28

3.1.2. IP as a product is highly reliant on advisors, and this is not likely to change soon 29

3.1.3. Individuals are purchasing CII independently without advice 31

3.2. Robo-advice has entered the life space, but is not expected for IP or CII soon 33

3.2.1. Life insurance products remain the focus for robo-advice tools 33

3.2.2. IP is too complicated to be sold directly or advised without a human 33

3.3. Insurers are developing their tools for advisors to aid distribution 33

3.3.1. Tools that help advisors sell protection products more efficiently are beneficial 33

3.3.2. Legal & General is testing how well advisors know its products 34

3.3.3. Legal & General helps advisors prevent policies being lost through its early warning system 34

3.3.4. LV=’s advisors can check likely underwriting outcomes using its new tool 34

3.3.5. Royal London has improved the flexibility of its online service for advisors 34

3.3.6. Royal London introduces e-signatures to speed up applications 34

4. COMPETITOR DYNAMICS 36

4.1. The injury and illness protection market is dominated by a few players 36

4.1.1. Legal & General dominates the critical illness market by number of contracts 36

4.1.2. LV= and Friends Life account for half of new IP sales 36

4.1.3. Innovation and technology is driving competition and will decide who wins 37

4.2. The CII market is trying to cover more conditions at a cheaper rate 38

4.2.1. Choosing how many conditions to cover is a cause for debate for critical illness insurers 38

4.2.2. AIG Life has launched a CII product that only covers for cancer, heart attack, and stroke 39

4.3. Legal & General leads the critical illness market 39

4.3.1. Legal & General’s CII has a range of benefits at no additional cost 39

4.3.2. Legal & General’s IP product has a range of options to reduce premiums 39

4.4. Friends Life is now part of the Aviva Group 40

4.4.1. Friends Life will move under the Aviva brand in October 2017 40

4.4.2. Aviva’s and Friends Life’s new critical illness product offers three tiers of cover 41

4.4.3. Aviva’s and Friends Life’s new IP policy allows advisors to flexibly design cover 41

4.5. LV= leads the IP market 42

4.5.1. LV= offers a specialist IP policy for doctors and surgeons 42

4.5.2. LV=’s critical illness product is only available as a rider alongside its term life insurance policy 42

4.5.3. LV= and Allianz are combining to form a joint venture in general insurance 42

4.5.4. LV= is looking to develop its rehabilitation services to aid the recovery of claimants 42

4.6. Royal London offers its Helping Hand support service to customers 43

4.6.1. Royal London’s IP customers can choose when payouts start and how long they last 43

4.6.2. Royal London’s CII covers 43 definitions and 14 additional conditions 43

4.6.3. Royal London has removed the age limit for its IP product 43

4.7. Vitality works to differentiate itself from other players 43

4.7.1. Vitality’s IP customers can benefit from rewards and discounts 43

4.7.2. Vitality’s serious illness payouts are based on severity, allowing it to cover more conditions 44

5. THE MARKET GOING FORWARD 46

5.1. The CII and IP markets are forecast to grow to 2021 46

5.1.1. The IP market is forecast to grow by

17.0% from 2016 to 2021 46

5.1.2. IP and CII policies can reduce Universal Credit payments, outweighing their value 47

5.1.3. The standalone critical illness market is forecast to grow by

11.5% from 2016 to 2021 48

5.1.4. Protection providers want government help to promote IP and CII 50

5.2. Policies are becoming personalized 51

5.2.1. Wearable healthcare technology is assessing individual risk 51

5.2.2. Genomic profiling could be used to assess risk in the future 51

5.2.3. Personalization could create an uninsurable underclass 52

5.2.4. Specialist policies for existing conditions could enter CII and IP 52

5.3. Providers want to actively help individuals manage their health 52

5.3.1. Providers could offer wearable technology that diagnoses and manages medical conditions 52

5.3.2. Facial analytics is being developed to detect early signs of disease 53

5.3.3. Aviva is investing in companies helping to protect and prevent against injury and illness 53

5.3.4. Rehabilitation and support services are helping customers get back to work 53

5.3.5. Wellbeing apps are being launched 54

5.3.6. Providers are launching digital healthcare and virtual GP services 54

6. APPENDIX 56

6.1. Abbreviations and acronyms 56

6.2. Bibliography 56

6.3. Further reading 57

Table

List of Tables

Table 1: IP and CII within the total protection market, by contracts and premiums, 2011-16 15

Table 2: CII cover as a bolt-on to other protection products, 2016 20

Table 3: Distribution of IP contracts and premiums, split by channel, 2013-16 31

Table 4: Number of conditions covered by the top five CII providers in 2016 38

Table 5: Percentage payout of claims by severity and Vitality serious illness cover policy type 45

Figures

List of Figures

Figure 1: The non-mortgage-related market saw the biggest decline due to the RDR 12

Figure 2: Contracts and premiums for IP and CII grew in 2016 14

Figure 3: Premiums have performed better than contract numbers for IP 16

Figure 4: The standalone CII market doubled in size from 2015 to 2016 18

Figure 5: The number of contracts in the group market has fallen drastically since 2013 22

Figure 6: Cancer is the highest cost for critical illness insurers 26

Figure 7: Mental illness claims are the highest cost to IP insurers 27

Figure 8: The restricted advice channel has shrunk as a result of the RDR 29

Figure 9: Independent and restricted advice are the main channels of distribution for IP 30

Figure 10: All distribution channels for CII have grown, but the non-advised channel is gaining market share 32

Figure 11: Legal & General dominates the CII market, while LV= leads the way in IP 37

Figure 12: Vitality rewards customers who lead an active lifestyle 44

Figure 13: The IP market is forecast to grow by 17.0% to £56.5m from 2016 to 2021 48

Figure 14: The standalone CII market will grow 11.5% to £15.7m from 2016 to 2021 50

Frequently asked questions

UK Protection Insurance 2017: Critical Illness & Income Protection thematic reports
Currency USD
$3,450

Can be used by individual purchaser only

$10,350

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

UK Protection Insurance 2017: Critical Illness & Income Protection was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at UK Protection Insurance 2017: Critical Illness & Income Protection in real time.

  • Access a live UK Protection Insurance 2017: Critical Illness & Income Protection dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.